US 7,067,135 B2 · Methods and compositions for the treatment and prevention of Staphylococcus aureus infections

Abstract

The invention features methods and compositions for treatment or prevention of infection by, or disease caused by infection with, Staphylococcus spp., particularly S. aureus.

Claims2

Dependent claims

An isolated RNAIII Activating Protein polypeptide having an amino acid sequence of SEQ ID NO:

Dependencies are inferred from the claim text.

Facts

Application

09/839,695Filed 19 Apr 2001 · continuation in part

Priority

19 Dec 1997

Published

US 2004/0077534 A122 Apr 2004

Granted

27 Jun 2006

Term ends

Not estimatedThe source records don’t support an estimate.

Classification10 codes

C07K 16/1271
Gram-positive bacteria: micrococcaceae ; Staphylococcaceae , e.g. Staphylococcus
A61K 38/164
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from bacteria
A61K 39/085
Bacterial antigens: staphylococcus
A61P 31/00
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Family

Application60/068,094Us provisional application · filed 19 Dec 1997

Application09/054,331Parent of this continuation-in-part · filed 2 Apr 1998

US 2004/0077534 A1Pre-grant publication · published 22 Apr 2004

US 6,291,431 B1Parent of this continuation-in-part

US 7,067,135 B2This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

The invention features methods and compositions for treatment or prevention of infection by, or disease caused by infection with, Staphylococcus spp., particularly S. aureus.

Methods and compositions for the treatment and prevention of Staphylococcus aureus infections

Life of this patent

Abstract

Claims2

Methods and compositions for the treatment and prevention of Staphylococcus aureus infections

Life of this patent

Abstract

Claims2